NEUROENDOCRINE PEPTIDES AND THEIR RECEPTORS REGULATING CORTICOTROPHES

神经内分泌肽及其调节皮质激素的受体

基本信息

  • 批准号:
    6296404
  • 负责人:
  • 金额:
    $ 21.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-06-01 至 2000-05-31
  • 项目状态:
    已结题

项目摘要

Corticotropin releasing factor (CRF) is the key neuroregulatory of the releasing factor (CRF) is the key neuroregulator of the mediate many endocrine, neuroendocrine, autonomic and behavioral responses mediate many endocrine neuroendocrine autonomic and behavioral responses the peptide and its binding sites when considered with many biological the peptide and its binding sites when considered with many biological the central nervous, immune and other systems. The actions of CRF are within the central nervous immune and other systems. The actions of CRF of which was cloned by this project during the last grant period and shown first of which was cloned by this project during the last grant period distributed in pituitary corticotropes and throughout the CNS. We will cyclase and to be distributed in pituitary corticotropes and throughout receptor by CRF and other corticotrope regulators such as glucocorticoids receptor by CRF and other corticotrope regulators such as glucocorticoids mechanisms of ligand-mediated down regulation and desensitization will be mechanisms of ligand-mediated down regulation and desensitization will binding and signal generation and for regulation of receptor sensitivity binding and signal generation and for regulation of receptor sensitivity Project II, the ligand structural requirements for binding to the cloned Project II the ligand structural requirements for binding to the cloned protein, also cloned and studied by us during the past period. An protein also cloned and studied by us during the past period. An we will screen for cDNA's encoding this gene and will complete its analysis we will screen for cDNA s encoding this gene and will complete its will be identified by molecular biological techniques or will be purified related ligands will be identified by molecular biological techniques or will be purified and chemically characterized
促肾上腺皮质激素释放因子(CRF)是神经系统的关键调控因子

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WYLIE W. VALE其他文献

WYLIE W. VALE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WYLIE W. VALE', 18)}}的其他基金

CRF and urocortins and their receptors
CRF 和尿皮质素及其受体
  • 批准号:
    7429657
  • 财政年份:
    2007
  • 资助金额:
    $ 21.48万
  • 项目类别:
Biology of Neuroendocrine Peptides
神经内分泌肽生物学
  • 批准号:
    7499462
  • 财政年份:
    2007
  • 资助金额:
    $ 21.48万
  • 项目类别:
ROLE OF BETAGLYCAN IN INHIBIN ANTAGONISM OF ACTIVIN
Betaglycan 在激活素抑制素拮抗作用中的作用
  • 批准号:
    7537246
  • 财政年份:
    2007
  • 资助金额:
    $ 21.48万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    6956177
  • 财政年份:
    2005
  • 资助金额:
    $ 21.48万
  • 项目类别:
CRF and urocortins and their receptors
CRF 和尿皮质素及其受体
  • 批准号:
    6956156
  • 财政年份:
    2005
  • 资助金额:
    $ 21.48万
  • 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
  • 批准号:
    6769849
  • 财政年份:
    2004
  • 资助金额:
    $ 21.48万
  • 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
  • 批准号:
    6898291
  • 财政年份:
    2004
  • 资助金额:
    $ 21.48万
  • 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
  • 批准号:
    7066615
  • 财政年份:
    2004
  • 资助金额:
    $ 21.48万
  • 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
  • 批准号:
    7426782
  • 财政年份:
    2004
  • 资助金额:
    $ 21.48万
  • 项目类别:
Cripto Antagonism of Activin and TGF-Beta Signalling
激活素和 TGF-β 信号传导的 Cripto 拮抗作用
  • 批准号:
    7236161
  • 财政年份:
    2004
  • 资助金额:
    $ 21.48万
  • 项目类别:

相似海外基金

ENDOCRINE PHARMACOLOGY OF PSYCHOTROPIC DRUGS
精神药物的内分泌药理学
  • 批准号:
    2122169
  • 财政年份:
    1995
  • 资助金额:
    $ 21.48万
  • 项目类别:
ENDOCRINE PHARMACOLOGY OF PSYCHOTROPIC DRUGS
精神药物的内分泌药理学
  • 批准号:
    2391024
  • 财政年份:
    1995
  • 资助金额:
    $ 21.48万
  • 项目类别:
ENDOCRINE PHARMACOLOGY OF PSYCHOTROPIC DRUGS
精神药物的内分泌药理学
  • 批准号:
    2683835
  • 财政年份:
    1995
  • 资助金额:
    $ 21.48万
  • 项目类别:
ENDOCRINE PHARMACOLOGY OF PSYCHOTROPIC DRUGS
精神药物的内分泌药理学
  • 批准号:
    2122170
  • 财政年份:
    1995
  • 资助金额:
    $ 21.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了